Expression of Concern
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 12, Issue 10 pp 9781—9792
LncRNA DSCAM-AS1 promotes colorectal cancer progression by acting as a molecular sponge of miR-384 to modulate AKT3 expression
Figure 1. DSCAM-AS1 was upregulated and correlated with poor prognosis in patients with CRC. (A) qRT-PCR shows the lncRNA DSCAM-AS1 expression level in 56 pairs CRC tissues and non-tumor tissues. (B) qRT-PCR shows the lncRNA DSCAM-AS1 expression level in a normal human colon epithelial cell line NCM460 and four human CRC cell lines (LOVO, PKO, SW480 and HT29).(C) 56 patients with CRC were divided into two groups based on a median DSCAM-AS1 value and the association of DSCAM-AS1 expression with overall survival was analyzed with a Kaplan–Meier plot. P < 0.05, **P < 0.01.